SubHero Banner

Pfizer/BioNTech and Moderna COVID-19 vaccines (Omicron variant XBB.1.5) – CDC recommends updated vaccine

September 12, 2023 - The Centers for Disease Control and Prevention (CDC) convened its Advisory Committee on Immunization Practices (ACIP) to evaluate the 2023-2024 (monovalent, XBB containing) COVID-19 vaccines as authorized by the Food and Drug Administration (FDA) under Emergency Use Authorization (EUA) or approved by Biologics License Application (BLA). FDA approved/authorized the new vaccines on September 11, 2023.

Download PDF